| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/2007 | US20070048366 Gelatin-based coatings having improved durability |
| 03/01/2007 | US20070048336 Combination therapy of peptide vaccination and estramustine treatment |
| 03/01/2007 | US20070048333 CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes |
| 03/01/2007 | US20070048328 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048322 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048317 Method of treating fibroproliferative disorders |
| 03/01/2007 | US20070048316 Method of reducing proliferation of cells in a mammal |
| 03/01/2007 | US20070048312 Mixture comprising A beta -derived diffusible ligand (ADDL) specific immunoglobulin which binds soluble amyloid beta protein for use in diagnosis, prevention and treatment of nervous sytem disorders |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048309 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048304 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048297 Human secreted proteins |
| 03/01/2007 | US20070048296 Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| 03/01/2007 | US20070048295 Method for preparing alginate capsules |
| 03/01/2007 | US20070048288 Shear thinning polymer cell delivery compositions |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048284 Cardiac arrhythmia treatment methods |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048282 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 03/01/2007 | US20070048281 Vaccination with a synergistic combination of a Hepatitis C Virus E1 vaccine and an antiviral agent, such as an interferon; improved immunostimulation |
| 03/01/2007 | US20070048277 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048276 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070048275 Hepatitis C; antiviral polypeptide |
| 03/01/2007 | US20070048274 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048273 Methods of treating cancer using IL-21 |
| 03/01/2007 | US20070048272 Methods of treating cancer using IL-21 |
| 03/01/2007 | US20070048271 Methos of treating cancer using IL-21 |
| 03/01/2007 | US20070048270 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048269 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048268 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048267 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048266 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048265 Methods of treating autoimmune diseases using il-21 |
| 03/01/2007 | US20070048264 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 03/01/2007 | US20070048263 composition with a IL-21 protein at a concentration of about 10 mg/ml IL-21 protein in about 10 mM histidine, 4.7% mannitol at pH 5.3; using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048262 Methods for treating viral infection using il-28 and il-29 |
| 03/01/2007 | US20070048261 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
| 03/01/2007 | US20070048260 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048259 Cytokine zalpha11 ligand |
| 03/01/2007 | US20070048258 Use of human Zven proteins and polynucleotides |
| 03/01/2007 | US20070048257 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | US20070048255 Method for treatment of demyelinating central nervous system disease |
| 03/01/2007 | US20070048254 Generation of dendritic cells |
| 03/01/2007 | US20070048253 Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells |
| 03/01/2007 | US20070048245 Comprises rapid acting muscle relaxant derived from extract of Acmella oleracea plant |
| 03/01/2007 | US20070048225 NK3 receptor in vivo assay |
| 03/01/2007 | US20070048223 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048222 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | DE20122679U1 Behandlung von Knochenerkrankungen Treatment of bone diseases |
| 03/01/2007 | CA2620903A1 Ply-gbs mutant lysins |
| 03/01/2007 | CA2620364A1 Methods for treatment of headaches by administration of oxytocin |
| 03/01/2007 | CA2620228A1 Therapeutically active .alpha.-msh analogues |
| 03/01/2007 | CA2620125A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/01/2007 | CA2619992A1 Cleavage of antifolate compounds |
| 03/01/2007 | CA2619654A1 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 03/01/2007 | CA2619568A1 Topical formulations of histone deacetylase inhibitors and methods of using the same |
| 03/01/2007 | CA2619481A1 Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 03/01/2007 | CA2619426A1 Exendin for treating diabetes and reducing body weight |
| 03/01/2007 | CA2619406A1 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 03/01/2007 | CA2617984A1 Methods and compositions for treating gastrointestinal radiosensitivity in a subject |
| 03/01/2007 | CA2615560A1 Compositions and methods to control angiogenesis with cupredoxins |
| 03/01/2007 | CA2603144A1 Botulinum toxin in treatment of clubfoot relapse |
| 02/28/2007 | EP1757944A1 A method of determining the initial dose of vitamin D compounds |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757704A2 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757306A1 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 02/28/2007 | EP1757304A1 Pharmaceutical composition and its use for the prophylactic or therapeutic treatment of retroviral diseases |
| 02/28/2007 | EP1757303A1 Human lysozyme medicine, its manufacturing method and application thereof |
| 02/28/2007 | EP1757302A1 Adiponectin expression inducer and utilization of the same |
| 02/28/2007 | EP1757301A1 The substance containing proteins and insoluble dietary fibers derived from the germinated seed of a grass family plant and uses thereof |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1757269A2 Pulmonary formulation comprising silicon particles |
| 02/28/2007 | EP1756576A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 10 (dpp10) |
| 02/28/2007 | EP1756569A1 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis |
| 02/28/2007 | EP1756272A2 Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1756160A2 Oligomeric peptides and their use for the treatment of hiv infections |